Navigation Links
Tata Industries picks up stake in Indigene Pharmaceuticals

Tata Industries Ltd today said it has acquired a significant stake in Indigene Pharmaceutical, a subsidiary of US-based indigene Pharma Inc// , for an undisclosed amount.

Indigene, which is involved in biopharmaceuticals, has been in the business of both prescription and consumer healthcare products.

Commenting on the strategic alliance with Indigene, Tata Group Chairman Ratan Tata said the group has been actively seeking opportunities in knowledge-based industries.

"Our strategic alliance with Tatas enables us to leverage the Group's reputation and vision, nurturing the growth phase of ventures and creating fundamentally strong organisations," Indigene Chairman and CEO M Vaman Rao said in a statement.
'"/>




Page: 1

Related medicine news :

1. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
2. Pharmacia may take 51.5 percent Abbott stake
3. Children! Protecting them from medical mistakes
4. Costly mistakes help better understand OCD: obsessive compulsive disorder
5. Epidural Mistakes Proves To Be Fatal Blunders
6. Delhi Medical Board to Probe Mistaken Surgery on Child
7. Learning to Prevent Medical Mistakes in Caring for Stroke Patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tata Industries picks stake Indigene Pharmaceuticals

(Date:7/23/2014)... (PRWEB) July 23, 2014 On July 21, ... childhood safety advocate Jack Tracey for an episode that spoke ... the episode, Deierlein asks Tracey to talk some about the ... international in its mission, it was started right here in ... initially it was to help survivors of sexual abuse. Their ...
(Date:7/23/2014)... 23, 2014 Beverly Hills plastic ... surgery procedures to patients who want to rejuvenate their ... affecting any part of the face, Dr. Diamond empowers ... want. Throughout life, facial skin and structure develop wrinkles, ... than they really are. Each patient is different in ...
(Date:7/23/2014)... July 23, 2014 Seedstock today announced ... and Agriculture (2003-2010) Arthur Gen “A.G.” Kawamura, will deliver ... Agriculture Innovation Conference – “Reintegrating Ag: Local Food Systems ... , to be held Tuesday and Wednesday, Nov. 11-12, ... benefits that result from the development of robust local ...
(Date:7/23/2014)... July 23, 2014 Follow ... vital role in the marketing mix, with its ... to influencing customers’ purchase decision. In a competitive ... and efficient packaging provides ample opportunities for sales ... advanced packaging technologies such as blister and other ...
(Date:7/23/2014)... 2014 FCCI Insurance Group has been ... American Heart Association for helping employees eat better and ... Fit-Friendly Worksite in 2013, 2011, and 2010, and as ... employee health and wellness an important priority. We’re committed ... at the top of their game, and we are ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2Health News:Beverly Hills Plastic Surgeon, Dr. Diamond, is Now Offering Facial Plastic Surgery Procedures 2Health News:Seedstock Names Former CA Secretary of Agriculture as Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Former CA Secretary of Agriculture as Sustainable Agriculture Conference Keynote Speaker 3Health News:Increasing Focus on Packaging as a Marketing Tool Drives the Blister & Other High Visibility Packaging Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Increasing Focus on Packaging as a Marketing Tool Drives the Blister & Other High Visibility Packaging Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Increasing Focus on Packaging as a Marketing Tool Drives the Blister & Other High Visibility Packaging Market, According to New Report by Global Industry Analysts, Inc. 4Health News:FCCI Insurance Group Recognized as an American Heart Association Fit-Friendly Worksite 2Health News:FCCI Insurance Group Recognized as an American Heart Association Fit-Friendly Worksite 3
... ... of the best medical malpractice attorneys in New York, and a former ... to talk to their doctor about the benefits and risks of radiation ... how to evaluate the treatment they are getting, ,how to discuss the ...
... more likely to die in the month following their operations ... by Johns Hopkins researchers suggests. The study, to be ... Care , finds that newly diagnosed cancer patients particularly ... Type 2 diabetes have a 50 percent greater risk of ...
... new study from University of Utah psychologists found a small ... 97.5 percent of those studied, they can safely drive while ... described by the researchers as "supertaskers" constitute only 2.5 ... ability to successfully do two things at once: in this ...
... ... true alternative to smoking. They deliver more of the flavor and you don,t lose any ... MiniVap, Magic Flight, Vapir, BM Innovators, and Eterra will indroduce new models in 2010. ... (PRWEB) March 28, 2010 ...
... Affordable prices for ... ... bearing not only the responsibility of preserving the peace and saving lives but paying exorbitant ... light bars at an affordable price. With a fully interactive website and telephone ...
... ... there a link between alcohol and depression? , ... (PRWEB) March 28, 2010 -- Statistics prove the link between alcohol ... have tended to view alcohol and depression as separate issues. However increasingly, research is showing ...
Cached Medicine News:Health News:New York Medical Malpractice Attorney Recommends Cancer Patients Take Precautionary Steps Before Undergoing Radiation Therapy 2Health News:New York Medical Malpractice Attorney Recommends Cancer Patients Take Precautionary Steps Before Undergoing Radiation Therapy 3Health News:Diabetes raises risk of death in cancer surgery patients 2Health News:Few drive well while yakking on cell phones 2Health News:Few drive well while yakking on cell phones 3Health News:New Vaporizer Technologies Revolutionize Smoking 2Health News:New Vaporizer Technologies Revolutionize Smoking 3Health News:High Quality Strobe Lights and Light Bars at an Affordable Price 2Health News:Linwood Group Reveal Whether There is a Link Between Alcohol and Depression 2Health News:Linwood Group Reveal Whether There is a Link Between Alcohol and Depression 3
(Date:7/23/2014)... 2014  Nonin Medical, Inc., the inventor of finger ... announced today that Mark VanderWerf , Nonin,s Vice ... of the American Telemedicine Association,s (ATA) Industry Council and ... The ATA is the leading international resource and advocate ... ATA and its diverse membership work to transform healthcare ...
(Date:7/23/2014)... PLYMOUTH MEETING, Pa. , July 23, ... MKT: INO) today announced successful results from ... of VGX-3100 in women with biopsy-proven cervical ... papillomavirus (HPV) types 16 or 18. Treatment ... histopathological regression of CIN2/3 to CIN1 or ...
(Date:7/23/2014)... July 23, 2014  Lightlake Therapeutics Inc. ("Lightlake") ... based on its expertise in opioid antagonists, announced ... drug application ("IND") with respect to its naloxone-based ... today that it has received an additional commitment ... part of the National Institutes of Health ("NIH"), ...
Breaking Medicine Technology:Nonin Medical Announces that Mark VanderWerf has been Elected Chairman of the American Telemedicine Association's Industry Council 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3
... Abbott (NYSE: ABT ) scientists and independent researchers ... Abbott,s investigational oncology compounds at this year,s American Society ... June 4-8 in Chicago . The presentations include ... and a humanized monoclonal antibody directed against CS1. Abbott,s oncology ...
... EAST HANOVER, N.J. , June 3 ... study of Afinitor® (everolimus) tablets plus best supportive care met ... or time without tumor growth, in patients with advanced pancreatic ... I n A dvanced N euroendocrine T ...
Cached Medicine Technology:Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 2Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 3Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 4Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 5Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 6Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 7Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 2Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 3Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 4Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 5Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 6Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 7
... Forma 1400 Series ... specifically to revolutionize working ... cabinet. The most comfortable, ... Class II cabinet on ...
... The Premier 12 Holter Analysis Kit incorporates ... Dispersion with other powerful DMS Holter analysis ... TWA analysis possible in less than 10 ... TWA, for visual verification and validation. The ...
... Designed for ease of use and patient ... smooth edges for comfort and is available ... to a perfect fit. For hard to ... trach collar to your specifications. Don't just ...
... more comfortable, and you will too., ... and to avoid the knotty problems associated ... ties, consider the Dale® Tracheostomy Tube Holder. ... narrow fastener tabs of the Dale® Tracheostomy ...
Medicine Products: